Inventor · disambiguated record
V. Satish Kumar
Also filed as: KUMAR V S · KUMAR V SATISH
31 granted patents·12 pending applications·466 citations·filing 2005–2024
97Inventor score
Top patents by PatentIndex Score
43 records- 0198US7560434B2AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2005·Granted Jul 14, 2009·92 cites·29 claims
- 0297US11230530B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Jan 25, 2022·5 cites·22 claims
- 0397US11203574B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Dec 21, 2021·5 cites·22 claims
- 0497US11192861B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Dec 7, 2021·5 cites·27 claims
- 0597US10689346B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jun 23, 2020·10 cites·38 claims
- 0697US10633345B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2018·Granted Apr 28, 2020·10 cites·25 claims
- 0797US10329260B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2018·Granted Jun 25, 2019·26 cites·45 claims
- 0897US10125102B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2015·Granted Nov 13, 2018·24 cites·16 claims
- 0997US7994139B2Antiviral therapeutic agentsBIOCRYST PHARM INC·Filed 2009·Granted Aug 9, 2011·81 cites·24 claims
- 1096US11708333B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·2 cites·23 claims
- 1196US11708332B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·2 cites·16 claims
- 1296US11685721B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jun 27, 2023·2 cites·33 claims
- 1396US7514410B2Hepatitis C therapiesBIOCRYST PHARM INC·Filed 2006·Granted Apr 7, 2009·80 cites·42 claims
- 1495US11708347B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·3 cites·9 claims
- 1595US11370774B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jun 28, 2022·4 cites·3 claims
- 1695US8440813B2Antiviral nucleoside analogsBABU YARLAGADDA S·Filed 2008·Granted May 14, 2013·42 cites·1 claims
- 1795US8133870B2Therapeutic furopyrimidines and thienopyrimidinesBABU YARLAGADDA S·Filed 2005·Granted Mar 13, 2012·32 cites·24 claims
- 1894US11866418B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2022·Granted Jan 9, 2024·2 cites·17 claims
- 1993US11021458B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jun 1, 2021·5 cites·12 claims
- 2092US8163703B2Hepatitis C therapiesBABU YARLAGADDA S·Filed 2009·Granted Apr 24, 2012·27 cites·31 claims
- 2192US2025257040A1Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 2292US2025270171A1Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 2391US12043610B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2022·Granted Jul 23, 2024·1 cites·9 claims
- 2488US12162838B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2023·Granted Dec 10, 2024·0 cites·28 claims
- 2588US12116346B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2023·Granted Oct 15, 2024·0 cites·26 claims
- 2686US11661426B2Imidazole-containing inhibitors of ALK2 kinaseBIOCRYST PHARM INC·Filed 2018·Granted May 30, 2023·2 cites·42 claims
- 2786US2024294494A1Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 2883US10562850B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2016·Granted Feb 18, 2020·2 cites·23 claims
- 2980US11066360B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jul 20, 2021·1 cites·20 claims
- 3077US12054492B2Imidazole-containing inhibitors of ALK2 kinaseBIOCRYST PHARM INC·Filed 2023·Granted Aug 6, 2024·0 cites·37 claims
- 3177US10759759B2Prodrugs of kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2017·Granted Sep 1, 2020·1 cites·30 claims
- 3271US11807605B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Nov 7, 2023·0 cites·35 claims
- 3368US11618731B2Prodrugs of kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Apr 4, 2023·0 cites·13 claims
- 3455US2011144321A1Synthetic intermediates and processesBIOCRYST PHARM INC·Filed 2009·Application pending·0 cites
- 3553US2011165183A1Piperidine derivatives as jak3 inhibitorsBIOCRYST PHARM INC·Filed 2009·Application pending·0 cites
- 3653US2012213735A1Therapeutic furopyrimidines and thienopyrimidinesBABU YARLAGADDA S·Filed 2012·Application pending·0 cites
- 3752US2015291596A1Antiviral azasugar-containing nucleosidesBIOCRYST PHARM INC·Filed 2013·Application pending·0 cites
- 3852US2013078218A1Hepatitis c therapiesBABU YARLAGADDA S·Filed 2012·Application pending·0 cites
- 3947US2017267681A1Antiviral azasugar-containing nucleosidesBIOCRYST PHARM INC·Filed 2017·Application pending·0 cites
- 4046US2012142617A1Antiviral therapeutic agentsBABU YARLAGADDA S·Filed 2011·Application pending·0 cites
- 4142US8344132B2Methods for the preparation of 9-deazapurine derivativesBIOCRYST PHARMACETICALS INC·Filed 2006·Granted Jan 1, 2013·0 cites·6 claims
- 4236US2012149691A1Pyrrolo [1,2-b] Pyridazine Derivatives as Janus Kinase InhibitorsBABU YARLAGADDA S·Filed 2010·Application pending·0 cites
- 4336US2012149662A1Heterocyclic Compounds as Janus Kinase InhibitorsBABU YARLAGADDA S·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when V. Satish Kumar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →